S9900: Surgery With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Corey J. Langer, MD
Fox Chase Cancer Center
Study Chair - Joseph A. Treat, MD
Fox Chase Cancer Center
Study Chair - Paul A. Bunn, MD
University of Colorado, Denver
Study Chair - Randolph S. Marks, MD
Mayo Clinic
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
287 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Tom Baker Cancer Center - Calgary
Calgary, Alberta, Canada
- Cross Cancer Institute
Edmonton, Alberta, Canada
- Doctor Leon Richard Oncology Centre
Moncton, New Brunswick, Canada
- Saint John Regional Hospital
Saint John, New Brunswick, Canada
- Newfoundland Cancer Treatment and Research Foundation
St. John's, Newfoundland and Labrador, Canada
- Nova Scotia Cancer Centre
Halifax, Nova Scotia, Canada
- Northeastern Ontario Regional Cancer Centre at Regional Hospital of Sudbury Regional Hospital
Greater Sudbury, Ontario, Canada
- Margaret and Charles Juravinski Cancer Centre
Hamilton, Ontario, Canada
- Kingston Regional Cancer Centre
Kingston, Ontario, Canada
- Cancer Care Ontario-London Regional Cancer Centre
London, Ontario, Canada
- Ottawa Regional Cancer Centre
Ottawa, Ontario, Canada
- Northwestern Ontario Regional Cancer Care
Thunder Bay, Ontario, Canada
- Princess Margaret Hospital
Toronto, Ontario, Canada
- Toronto Sunnybrook Regional Cancer Centre
Toronto, Ontario, Canada
- Chus-Hopital Fleurimont
Fleurimont, Quebec, Canada
- Centre Hospitalier de L'Universite de Montreal
Montreal, Quebec, Canada
- Mcgill University
Montreal, Quebec, Canada
- Centre Hospitalier Universitaire de Quebec
Québec, Quebec, Canada
- Allan Blair Cancer Centre
Regina, Saskatchewan, Canada
- Saskatoon Cancer Centre
Saskatoon, Saskatchewan, Canada
- University of Alabama at Birmingham Comprehensive Cancer Center
Birmingham, Alabama, United States
- Comprehensive Cancer Institute
Huntsville, Alabama, United States
- Huntsville Hospital
Huntsville, Alabama, United States
- Mbccop - Gulf Coast
Mobile, Alabama, United States
- Montgomery Cancer Center
Montgomery, Alabama, United States
- Dch Cancer Treatment Center
Tuscaloosa, Alabama, United States
- Radiation Oncology Associates of West Alabama
Tuscaloosa, Alabama, United States
- Foundation for Cancer Research and Education
Phoenix, Arizona, United States
- Ccop - Mayo Clinic Scottsdale Oncology Program
Scottsdale, Arizona, United States
- Providence Saint Joseph Medical Center - Burbank
Burbank, California, United States
- Mount Diablo Medical Center
Concord, California, United States
- California Cancer Center
Fresno, California, United States
- Saint Agnes Cancer Center
Fresno, California, United States
- Sutter Health Western Division Cancer Research Group
Greenbrae, California, United States
- Loma Linda University Cancer Institute at Loma Linda University Medical Center
Loma Linda, California, United States
- Veterans Affairs Medical Center - Long Beach
Long Beach, California, United States
- Jonsson Comprehensive Cancer Center, Ucla
Los Angeles, California, United States
- Usc/norris Comprehensive Cancer Center and Hospital
Los Angeles, California, United States
- Ccop - Bay Area Tumor Institute
Oakland, California, United States
- Huntington Cancer Center at Huntington Hospital
Pasadena, California, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 1999
- Primary completion
- 31 May 2005
- Completion
- 30 Nov 2012
- Last update posted
- 31 Jan 2013
- Registered enrollment
- 354
- Registry id
- NCT00004011
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.